Acute alcohol intoxication induces significant alterations in brain cytokines. Since stress challenges also profoundly impact central cytokine expression, these experiments examined the influence of acute and chronic stress on ethanol-induced brain cytokine responses. In Experiment 1, adult male rats were exposed to acute footshock. After a post-stress recovery interval of 0, 2, 4, or 24 h, rats were administered ethanol (4 g/kg; intragastric), with trunk blood and brains collected 3 h later. In non-stressed controls, acute ethanol increased expression of Il-6 and IjBa in the hippocampus. In contrast, rats exposed to footshock 24 h prior to ethanol demonstrated potentiation of hippocampal Il-6 and IjBa expression relative to ethanol-exposed non-stressed controls. Experiment 2 subsequently examined the effects of chronic stress on ethanol-related cytokine expression. Following a novel chronic escalating stress procedure, rats were intubated with ethanol. As expected, acute ethanol increased Il-6 expression in all structures examined, yet the Il-6 response was attenuated exclusively in the hippocampus in chronically stressed rats. Later experiments determined that neither acute nor chronic stress affected ethanol pharmacokinetics. When ethanol hypnosis was examined, however, rats exposed to chronic stress awoke at significantly lower blood ethanol levels compared to acutely stressed rats, despite similar durations of ethanolinduced sedation. These data indicate that chronic stress may increase sensitivity to ethanol hypnosis. Together, these experiments demonstrate an intriguing interaction between recent stress history and ethanol-induced increases in hippocampal Il-6, and may provide insight into novel pharmacotherapeutic targets for prevention and treatment of alcohol-related health outcomes based on stress susceptibility.
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Introduction
Stress can have a profound impact on quality of life, with stressful life experiences implicated in the onset and progression of many physiological and psychological diseases including, but not limited to, cardiac disease (e.g., Dimsdale, 2008; Schwartz et al., 2012) , type II diabetes (Kelly and Ismail, 2015) , obesity (Adam and Epel, 2007; De Vriendt et al., 2009; Foss and Dyrstad, 2011) , chronic inflammatory diseases (e.g., psoriasis, rheumatoid arthritis; Affleck et al., 1997; Verhoeven et al., 2009) , visceral pain disorders (Moloney et al., 2016) , anxiety (Faravelli et al., 2012) , depression (Hammen, 2005; Mazure et al., 2000) , and drug and alcohol dependence (Blaine and Sinha, 2017; Lemieux and al'Absi, 2016; Piazza and Le Moal, 1996) . The mechanisms by which stress impacts physiological and psychological well-being continue to be intensely investigated. More recently, research has identified stress-induced activation of neuroimmune processes as a common pathway by which stress may impart deleterious consequences on health (for reviews see Kubera et al., 2011; Maes et al., 2009) . For instance, stress exposure in and of itself has been shown to result in increased expression of inflammatory related factors in the brain (e.g., Deak et al., 2015; Rossetti et al., 2016) , with the hypothalamus (Blandino et al., 2009; Deak et al., 2005b; Girotti et al., 2013; Grippo et al., 2005) , hippocampus (Goshen et al., 2008; Rossetti et al., 2016; You et al., 2011) , and cortex (Rossetti et al., 2016; You et al., 2011) all exhibiting sensitivity to these stress-induced changes. Additionally, it has been well-established that certain stressors can lead to changes in emotion-related behaviors, including increased expression of depressive-like behavior in preclinical models (Feng et al., 2012; Vitale et al., 2009; for review see Willner, 2005; Wu et al., 2012) . Importantly,
